ConductScience.org, home

Paper1985173

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.

Shpall EJ and 9 others. J Clin Oncol, 1991. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. Papers, record 1985173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1985173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
PubMed
Journal
J Clin Oncol
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
3.2
iCite
Revised in PubMed
2017-02-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shpall EJE J
2Jones RBR B
3Bast RC JrR C
4Rosner GLG L
5Vandermark RR
6Ross MM
7Affronti MLM L
8Johnston CC
9Eggleston SS
10Tepperburg MM

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Bone MarrowMajor topic
Bone Marrow TransplantationMajor topic
Breast NeoplasmsMajor topic
CyclophosphamideMajor topic
Adult
Bone Neoplasms
Brain Neoplasms
Doxorubicin
Drug Evaluation
Female
Fluorouracil
Humans
Methotrexate
Middle Aged
Neoplastic Stem Cells
Survival Rate

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
22312362Oncolytic virotherapy for hematological malignancies.Adv Virol2012https://conductscience.org/library/papers/22312362PubMed
22146617High-dose chemotherapy with autologous stem cell transplant for breast cancer: what have we learned 25 years later?Biol Blood Marrow Transplant2012https://conductscience.org/library/papers/22146617PubMed
20211576Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus.Cytokine Growth Factor Rev2010https://conductscience.org/library/papers/20211576PubMed
16435011A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.Bone Marrow Transplant2006https://conductscience.org/library/papers/16435011PubMed
15368078Stem-cell transplantation for the treatment of advanced solid tumors.Springer Semin Immunopathol2004https://conductscience.org/library/papers/15368078PubMed
10464772The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.Mol Biotechnol1999https://conductscience.org/library/papers/10464772PubMed
9764583High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.Br J Cancer1998https://conductscience.org/library/papers/9764583PubMed
8958216Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.J Clin Invest1996https://conductscience.org/library/papers/8958216PubMed
8932871Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.Breast Cancer Res Treat1996https://conductscience.org/library/papers/8932871PubMed
8825758Dose-intensified treatment of breast cancer: current results.J Mol Med (Berl)1995https://conductscience.org/library/papers/8825758PubMed
8258193Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8258193PubMed
8075009Current status of gene transfer into haemopoietic progenitor cells: application to Langerhans cell histiocytosis.Br J Cancer Suppl1994https://conductscience.org/library/papers/8075009PubMed
7691269New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.Breast Cancer Res Treat1993https://conductscience.org/library/papers/7691269PubMed
7531586The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.Med Oncol1994https://conductscience.org/library/papers/7531586PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1985173

GET https://conductscience.org/api/papers/v1/1985173/authors